BridgeBio Pharma, Inc. ROA

ROA of BBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including ROA growth rates and interactive chart. Return on Assets (ROA) is an indicator of how well a company utilizes its assets, by determining how profitable a company is relative to its total assets. A company with $1 million in net income and $10 million in average assets will have a 10% ROA.

Highlights and Quick Summary

  • Annual ROA for 2021 was -65.55% (a -2.47% decrease from previous year)
  • Annual ROA for 2020 was -67.21% (a 41.41% increase from previous year)
  • Annual ROA for 2019 was -47.53% (a -15.49% decrease from previous year)
  • Twelve month ROA ending September 30, 2022 was -64.96% (a 23.92% increase compared to previous quarter)
  • Twelve month trailing ROA decreased by -0.88% year-over-year
Trailing ROA for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
-64.96% -52.42% -62.51% -65.54%
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical ROA of BridgeBio Pharma, Inc.

Most recent ROAof BBIO including historical data for past 10 years.

Interactive Chart of ROA of BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. ROA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -65.55%
2020 -67.21%
2019 -47.53%
2018 -56.24%
2017 -10.86%

Business Profile of BridgeBio Pharma, Inc.

Sector: Healthcare
Industry: Biotechnology